Advertisement

Topics

Expanded use of Ipsen's Dysport approved by FDA

06:04 EDT 20 Jun 2017 | SmartBrief

Ipsen's Dysport, or abobotulinumtoxinA, has received FDA approval as a treatment for adult patients with lower-limb spasticit -More

Original Article: Expanded use of Ipsen's Dysport approved by FDA

NEXT ARTICLE

More From BioPortfolio on "Expanded use of Ipsen's Dysport approved by FDA"

Advertisement
Quick Search
Advertisement
Advertisement